Answers are grounded in this paper and cite their sources.
Shows 43% reduction in diarrhea-related hospitalizations in children under 5, indicating vaccine effectiveness.
We document a 43% reduction in rotavirus-associated hospitalizations among Ugandan children following introduction of the monovalent rotavirus vaccine (Rotarix). Declines were evident each year after Rotarix introduction and at each surveillance site, predominantly among infants. Continued monitoring for long-term impact is warranted given changes in the vaccine formulation in Uganda.
No takes yet. Share an insight, caveat, or question.
Nalunkuma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: